From dermatological conditions to COVID ‐19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

From dermatological conditions to COVID ‐19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy

Published:2020-11-30 Issue:1 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Criado Paulo Ricardo¹^ORCID,Miot Hélio Amante²,Pincelli Thais Prota Hussein³,Fabro Alexandre Todorovic⁴

Affiliation:

1. Department of Dermatology Centro Universitário Saúde ABC Santo André São Paulo Brazil

2. Department of Dermatology and Radiotherapy Faculdade de Medicina da Unesp Botucatu São Paulo Brazil

3. Department of Dermatology Mayo Clinic Jacksonville Florida USA

4. Department of Pathology and Forensic Medicine Faculdade de Medicina de Ribeirão Preto da USP São Paulo Brazil

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14565

Reference43 articles.

1. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

2. The unique characteristics of COVID-19 coagulopathy

3. Livedoid vasculopathy: A review of pathogenesis and principles of management

4. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen

5. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary livedoid vasculopathy following SARS‐CoV‐2 infection;Journal of the European Academy of Dermatology and Venereology;2023-12-14

2. COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project;JBI Evidence Implementation;2023-12

3. Prevalence of and risk factors for post-COVID: Results from a survey of 6,958 patients from Brazil;AN ACAD BRAS CIENC;2023

4. Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial;Journal of Clinical Medicine;2022-12-20

5. Livedoid vasculopathy – A diagnostic and therapeutic challenge;Frontiers in Medicine;2022-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3